• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Chief People Officer Varanakis Ann covered exercise/tax liability with 5,587 shares, decreasing direct ownership by 1% to 374,568 units (SEC Form 4)

    5/19/25 8:45:42 PM ET
    $LFST
    Medical/Nursing Services
    Health Care
    Get the next $LFST alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Varanakis Ann

    (Last) (First) (Middle)
    C/O LIFESTANCE HEALTH GROUP, INC.
    4800 N. SCOTTSDALE ROAD, SUITE 2500

    (Street)
    SCOTTSDALE AZ 85251

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    LifeStance Health Group, Inc. [ LFST ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief People Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    03/10/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 03/10/2025 F(1) 5,587 D $7.11 374,568 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of RSUs that vested on March 10, 2025. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
    By: /s/ Ryan Pardo, Attorney-in-Fact 05/19/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $LFST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LFST

    DatePrice TargetRatingAnalyst
    4/8/2025$9.00Overweight
    KeyBanc Capital Markets
    4/3/2025$8.00Buy
    Canaccord Genuity
    12/16/2024$10.00Neutral → Buy
    Goldman
    1/3/2024$7.00Underweight
    Barclays
    5/15/2023$8.00 → $9.00Outperform → Market Perform
    TD Cowen
    1/6/2023$8.00Equal-Weight → Overweight
    Morgan Stanley
    11/7/2022$7.25Buy
    Jefferies
    3/17/2022$19.00 → $10.00Buy → Neutral
    UBS
    More analyst ratings

    $LFST
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LifeStance Names Vaughn Paunovich as Chief Technology Officer

      SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

      5/14/25 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

      SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 6060781, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor R

      4/21/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/14/24 4:34:15 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/14/24 9:59:56 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by LifeStance Health Group Inc.

      SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)

      11/8/24 4:33:25 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Pardo Ryan covered exercise/tax liability with 12,280 shares, decreasing direct ownership by 1% to 915,735 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:52:55 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Director Burdick Kenneth A covered exercise/tax liability with 35,817 shares, decreasing direct ownership by 1% to 3,368,901 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:50:35 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Bourdon David covered exercise/tax liability with 10,884 shares, decreasing direct ownership by 1% to 888,239 units (SEC Form 4)

      4 - LifeStance Health Group, Inc. (0001845257) (Issuer)

      5/19/25 8:50:06 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    SEC Filings

    See more
    • LifeStance Health Group Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/14/25 9:34:10 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by LifeStance Health Group Inc.

      10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)

      5/7/25 4:42:46 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • SEC Form DEFA14A filed by LifeStance Health Group Inc.

      DEFA14A - LifeStance Health Group, Inc. (0001845257) (Filer)

      4/23/25 4:54:39 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Leadership Updates

    Live Leadership Updates

    See more
    • LifeStance Names Vaughn Paunovich as Chief Technology Officer

      SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp

      5/14/25 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • LifeStance Appoints Dr. Teresa DeLuca to Board of Directors

      SCOTTSDALE, Ariz., March 12, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of directors. "Dr. DeLuca's background

      3/12/24 9:00:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Financials

    Live finance-specific insights

    See more
    • LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

      SCOTTSDALE, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2025 earnings release before the market opens on Wednesday, May 7, 2025. LifeStance will host a live earnings conference call to discuss first quarter results on May 7, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 6060781, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor R

      4/21/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman

      Ryan McGroarty to Become Chief Financial Officer SCOTTSDALE, Ariz., Feb. 27, 2025 /PRNewswire/ -- LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that its Board of Directors has appointed Dave Bourdon as the Company's new Chief Executive Officer. Bourdon, who joined LifeStance as Chief Financial Officer in 2022, is succeeding Ken Burdick, who is retiring from his role as CEO and will assume the role of Executive Chairman. Bourdon has also been appointed to serve on the Board of Directors. In addition, Ryan McGroarty has been appointed to serve as the company's new Chief Financ

      2/27/25 6:02:00 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025

      SCOTTSDALE, Ariz., Feb. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2024 earnings release before the market opens on Thursday, February 27, 2025. LifeStance will host a live earnings conference call to discuss fourth quarter and full year results on February 27, 2025, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 4372752, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentati

      2/6/25 4:10:00 PM ET
      $LFST
      Medical/Nursing Services
      Health Care

    $LFST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • KeyBanc Capital Markets initiated coverage on LifeStance Health Group with a new price target

      KeyBanc Capital Markets initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $9.00

      4/8/25 9:29:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • Canaccord Genuity initiated coverage on LifeStance Health Group with a new price target

      Canaccord Genuity initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00

      4/3/25 8:18:32 AM ET
      $LFST
      Medical/Nursing Services
      Health Care
    • LifeStance Health Group upgraded by Goldman with a new price target

      Goldman upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $10.00

      12/16/24 6:31:31 AM ET
      $LFST
      Medical/Nursing Services
      Health Care